Richard Nolan Townsend, CEO: Lexeo Therapeutics LXEO Sell · Filed 24/07/12

Trade details

Type: Insider sale
Amount: $476,502.86
Shares · price: 27,931 sh · $17.06 a share
Held after: 120,795 sh
Stock: Lexeo Therapeutics LXEO
Person: Richard Nolan TownsendCEO
Trade date: 24/07/11
Filed: 24/07/12
Days to filing: 1 days

Sold 18.8% of holdings

Share of holding sold: 18.8%

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/11~24/08/10

Richard Nolan Townsend's recent trades

Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.6K
3,345 sh
$16.6K
Filed 08/18
Traded 08/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$116.2K
25,947 sh
$116.2K
Filed 07/01
Traded 07/01
Richard Nolan TownsendCEO
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/20
Traded 05/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/18
Traded 05/18
Richard Nolan TownsendCEO
Sell10b5-1 planLexeo Therapeutics
Sell10b5-1 plan
Lexeo Therapeutics
LXEO
$313K
55,000 sh
$313K
Filed 04/07
Traded 04/06

Richard Nolan Townsend, CEO — sold $476.5K of Lexeo Therapeutics LXEO · 18.8% of holdings · 10b5-1 plan | Whalegun